Explore New Strategies for Treating Retinal Vascular Disease at SMi’s 2nd annual Ophthalmic Drugs…
SMi Group are delighted to welcome the expertise from a senior panel of big pharma and ophthalmic organisations, as well as regulatory bodies, at the 2nd annual Ophthalmic Drugs 2018…
Read More...
Read More...
